2020
DOI: 10.1007/s10140-020-01849-3
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility of using point-of-care lung ultrasound for early triage of COVID-19 patients in the emergency room

Abstract: Purpose Diagnostic value of point-of-care lung ultrasound (POCUS) in detection of coronavirus disease (COVID-19) in an emergency setting is currently unclear. In this study, we aimed to compare diagnostic performance, in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy, of POCUS lung, chest CT, and RT-PCR for clinically suspected COVID-19 infections in patients submitting to the emergency room (ER). Material and methods This retrospective study e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
43
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(45 citation statements)
references
References 23 publications
2
43
0
Order By: Relevance
“…Given the extensive lung involvement in COVID-19 patients, LUS may have some potential utility in the management of acutely ill patients [15,16]. Some studies have reported an improvement in lung involvement assessment in COVID-19 by using LUS in the context of ED and ICU [17,18], but we only have found two prospective studies analyzing the prognostic value of LUS during the first pandemic wave of COVID-19 (March & April 2020) [19]. The first included 80 patients (17 outpatients, 42 hospitalized and 21 with orotracheal intubation or death), initially admitted to ED.…”
Section: Discussionmentioning
confidence: 99%
“…Given the extensive lung involvement in COVID-19 patients, LUS may have some potential utility in the management of acutely ill patients [15,16]. Some studies have reported an improvement in lung involvement assessment in COVID-19 by using LUS in the context of ED and ICU [17,18], but we only have found two prospective studies analyzing the prognostic value of LUS during the first pandemic wave of COVID-19 (March & April 2020) [19]. The first included 80 patients (17 outpatients, 42 hospitalized and 21 with orotracheal intubation or death), initially admitted to ED.…”
Section: Discussionmentioning
confidence: 99%
“…LUS demonstrated remarkable sensitivity and negative predictive value (NPV) among reviewed studies, with sensitivity ranging from 68% to 93.3% and a NPV ranging from 52%to 94.1% [78,80,82,87], suggesting the utility of LUS as a screening test to rule out COVID-19 lung infection. Data regarding specificity, positive predictive value (PPV) and diagnostic accuracy has been conflicting, with some studies demonstrating values as low as 21.3%, 19.2% and 33.3% for specificity, PPV and diagnostic accuracy, respectively [87], while others demonstrating higher values up to 92.9%, 84.6% and 93.3% for specificity, PPV and diagnostic accuracy, respectively [78]. Lu W et al demonstrated higher sensitivity and NPV of LUS in patients with moderate disease (77.8% and 88.9%, respectively) with both values reaching 100% in patients with severe disease.…”
Section: Diagnostic Performance Of Lusmentioning
confidence: 99%
“…Asymptomatic patients with positive COVID-19 RT-PCR showed pathological LUS findings in 22% of cases, including numerous B lines and pulmonary consolidation in a LUS allows a rapid diagnosis of COVID-19 pneumonia and a triage of patients within only 2-3 min in the ED with excellent sensitivity and negative predictive value in comparison to chest CT (93.3% and 94.1%, respectively) [47]. Furthermore, it is a radiation-free technique that may be a valuable alternative to CT scan for the diagnosis of pneumonia in pregnant women and paediatric settings [40].…”
Section: Diagnostic Value Of Lus and Ldct For Asymptomatic And Mild Covid-19 Infectionsmentioning
confidence: 99%